VKH
MRKR icon

Virtu KCG Holdings’s Marker Therapeutics MRKR Stock Holding History

Virtu KCG Holdings’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,211
Closed -$54K – 3274
2017
Q1 		$54K Buy
+1,211
New +$53.9K ﹤0.01% 2828

Other funds holding MRKR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Virtu KCG Holdings's MRKR Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Marker Therapeutics (MRKR) in Q2 2017, closing a stake of 1,211 shares — an estimated $54K sold.

Virtu KCG Holdings first reported a position in MRKR in Q1 2017 and held it in 1 quarter. The position peaked at $54K in Q1 2017. 5 funds tracked by Wall St. Rank hold MRKR as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Marker Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 1,211 Marker Therapeutics shares in Q2 2017, an estimated $54K.
  • Virtu KCG Holdings first reported a position in Marker Therapeutics in Q1 2017 and held it in 1 quarter.
  • Virtu KCG Holdings's Marker Therapeutics position peaked at $54K in Q1 2017.
  • 5 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.